Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Hikma Hits Back Over Amarin’s ‘Strawman’ Induced Infringement Claims
Rebuts Originator’s ‘Safe Harbor’ Attack Ahead Of Oral Arguments
Apr 17 2026
•
By
Dave Wallace
Hikma says that Amarin’s latest argument relies on “strawman assertions”
(Shutterstock)
More from IP & Litigation
More from Generics Bulletin